Access cutting-edge migraine treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access migraine specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related migraine treatment provided free
Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how safe and effective ubrogepant is in the acute treatment of migraine in children and adolescents. Ubrogepant is a drug approved for the acute treatment of migraine in adults. Children and adolescents (a
Sponsor: AbbVie
Check if you qualify for this migraine clinical trial in Little Rock, AR
If you're searching for migraine treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.